Beijing's diagnosis-related group payment reform pilot: Impact on quality of acute myocardial infarction care

Weiyan Jian, Ming Lu, Guofeng Liu, Kit Yee Chan, Adrienne N Poon

Research output: Contribution to journalArticlepeer-review

Abstract

In 2012, China's first diagnosis-related group (DRG) payment system was piloted in Beijing. This study explored whether this payment pilot improved quality and reduced costs of acute myocardial infarction (AMI) care in hospitals implementing DRG payment as compared to control hospitals. A difference-in-difference study design was used with regression and considered several quality indicators including aspirin at arrival, aspirin at discharge, β-blocker at arrival, β-blocker at discharge, statin at discharge, in-hospital mortality, and 30-day readmission rates. DRG payment mechanisms without specific mechanisms to promote care quality did not improve quality of AMI care. Future studies should study the impact of cost control mechanisms together with quality improvement efforts to assess how quality of care may be improved within the Chinese healthcare system. These lessons would be helpful to share with lower-middle-income countries undergoing rapid development that are transitioning to a significantly higher burden of non-communicable diseases.

Original languageEnglish
Pages (from-to)112590
JournalSocial Science & Medicine
Volume243
Early online date5 Oct 2019
DOIs
Publication statusE-pub ahead of print - 5 Oct 2019

Fingerprint

Dive into the research topics of 'Beijing's diagnosis-related group payment reform pilot: Impact on quality of acute myocardial infarction care'. Together they form a unique fingerprint.

Cite this